HCPCS drug code · CMS crosswalk
Imuldosa HCPCS Code
In short
Imuldosa is billed under HCPCS Q5098 — Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg. One billing unit is 1 mg. CMS's crosswalk lists 3 Imuldosa NDCs under this code.
Reference
- Q5098
- Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mgBilling unit: 1 mg
- Labelers
- Accord BioPharma, Inc
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: "lesser of" methodology applied; 8% of reference add-on applied. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Imuldosa units and claim line
Enter the dose given to get the Q5098 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Imuldosa NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 69448-0017-63 | Q5098 | Accord BioPharma, Inc | 0.5 | 45 |
| 69448-0018-63 | Q5098 | Accord BioPharma, Inc | 1 | 90 |
| 69448-0019-26 | Q5098 | Accord BioPharma, Inc | 26 | 130 |
Imuldosa: common questions
- What is the HCPCS code for Imuldosa?
- Imuldosa is billed under HCPCS Q5098 — Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg. One billing unit is 1 mg. CMS's crosswalk lists 3 Imuldosa NDCs under this code.
- How many Q5098 billing units are in a package of Imuldosa?
- CMS lists 45 to 130 billing units per package, depending on the NDC, where one unit is 1 mg. Units to report are based on the dose given, not the package.
- Is Q5098 a CPT code?
- No. Q5098 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.
Other codes for the same drug
- J3357Ustekinumab, for subcutaneous injection, 1 mg
- J3358Ustekinumab, for intravenous injection, 1 mg
- Q5099Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
- Q5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
- Q5137Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
- Q5138Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg
- Q5164Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mg
- Q9996Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
- Q9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
- Q9998Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg